Column

Transformative Employer Trends

The Value of Educating Employees Regarding Clinical Pathways

12/14/2023

This installment of the Transformative Employer Trends column explores how employers can educate employees about clinical pathways and potentially shift their negative impressions on pathways.

This installment of the...

12/14/2023

Journal of Clinical Pathways

Engaging Payers

Taking Aim at Multiple Sclerosis

12/13/2023

Michael Hoffman ;

Mike Edgeworth , MD;

Mike Edgeworth, MD, and Michael Hoffman discuss how providers and payers can better collaborate by using the quadruple aim to improve the patient experience, improve health outcomes, and reduce payer cost.

Mike Edgeworth, MD, and Michael...

12/13/2023

Journal of Clinical Pathways

Clinical Pathways GPS

Retired Physicians as Patient Navigators in Oncology: Guiding Patients Through the Complex Health Care System

09/19/2023

Richard G. Stefanacci , DO, MGH, MBA, AGSF, CMD;

Richard G. Stefanacci, DO, discusses the important role retired physicians play as patient navigators, with a focus on oncology care.

Richard G. Stefanacci, DO,...

09/19/2023

Journal of Clinical Pathways

Trending From ACCC

Key Findings from ACCC’s Digital Tools Survey

09/19/2023

Association of Community Cancer Centers

This column describes the findings from the 2022 Association of Community Cancer Centers (ACCC) patient survey to identify challenges and benefits associated with wearable devices and other digital tools.

This column describes the...

09/19/2023

Journal of Clinical Pathways

COA Viewpoint

Is the EOM DOA?

09/19/2023

Nicolas Ferreyros ;

Nicolas Ferreyros discusses the impact, or the lack of impact, the launch of the Enhancing Oncology Model has had on practices.

Nicolas Ferreyros discusses the...

09/19/2023

Journal of Clinical Pathways

Editor's Page

The Roles of Comprehensive Genomic Profiling, Next-Generation Sequencing, and AI in the Oncology Treatment Landscape

09/19/2023

Winston Wong , PharmD;

Editor-in-Chief Winston Wong, PharmD, provides insights on this issue’s content, highlighting the latest scientific developments in genetic testing for oncology biomarkers into clinical care.

Editor-in-Chief Winston Wong,...

09/19/2023

Journal of Clinical Pathways

Transformative Employer Trends

Navigating Personalized Medicine: Challenges and Opportunities for Employer Plans

09/19/2023

Ira Klein , MD, MBA, FACP;

F. Randy Vogenberg , PhD, FASHP;

This installment of the Transformative Employer Trends column further explores ways to address access to gene and cell therapies that are transforming management of benefits by employer plans.

This installment of the...

09/19/2023

Journal of Clinical Pathways

MAI Mindset

Clinical Pathways Impact on Treatment Selection

09/19/2023

Lee Blansett , MBA;

In this first entry of our new MAI Mindset column, Lee Blansett, MBA, provides an overview of how in addition to providing benefits, clinical pathways can also present challenges and potential risks for manufacturers.

In this first entry of our new...

09/19/2023

Journal of Clinical Pathways

Trending From ACCC

Delivery of Psychosocial Care in Oncology Summit

08/08/2023

Association of Community Cancer Centers

This column summarizes the sessions from the Association of Community Cancer Centers (ACCC) multistakeholder meeting, “A Call to Action: Delivery of Psychosocial Care in Oncology Summit,” which took place on March 8, 2023, in Washington, DC.

This column summarizes the...

08/08/2023

Journal of Clinical Pathways

Transformative Employer Trends

Gene and Cell Therapies: Changing Employer Plans to Optimize Patient Outcomes

08/08/2023

Alasdair Roe , ACII;

F. Randy Vogenberg , PhD, FASHP;

This installment of the “Transformative Employer Trends” column explores how employers can expand their benefit plans to include access to gene and cell therapies, while continuing to elevate the role of clinical pathways.

This installment of the...

08/08/2023

Journal of Clinical Pathways

Current Issue

October 2024

Volume 10

Issue 5

Current Issue

Issue Archive

Special Reports

Sponsored

JCP Special Report

The Value of Tissue-Based Genomic Profiling in Oncology

09/17/2024

Innovations in precision oncology have helped healthcare providers to create more personalized treatment plans and improve patient outcomes. View this special report to learn more.

Innovations in precision...

09/17/2024

Journal of Clinical Pathways

Sponsored

Special Report

Shedding Light on Non-Small Cell Lung Cancer & Its Impact on Patients

04/03/2023

This supplement aims to raise awareness about non-small cell lung cancer (NSCLC) and its impact on patients by providing comprehensive information to help improve early detection and appropriate care.

This supplement aims to raise...

04/03/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Brukinsa® (Zanubrutinib) for Chronic Lymphocytic Leukemia

03/31/2023

In this product monograph, read an interview with Jeff P. Sharman, MD, as he discusses important BRUKINSA® trial data including efficacy, safety, dosing, administration, and other relevant data. These key findings supported the Food and Drug...

In this product monograph, read...

03/31/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

Tumor Lysis Syndrome: Early Diagnosis and Management

01/04/2023

This review summarizes the diagnosis, pathophysiology, and evidence-based guidelines for the prevention and management of tumor lysis syndrome, a common, acute, life-threatening disease primarily in patients with hematologic cancers and solid...

This review summarizes the...

01/04/2023

Journal of Clinical Pathways

Sponsored

JCP Special Report

A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

08/09/2022

In an interview with Journal of Clinical Pathways, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

In an interview with Journal of...

08/09/2022

Journal of Clinical Pathways

Updated NCCN Guidelines on B-Cell Lymphomas

Sponsored

JCP Special Report

Overview of the Updated NCCN Guidelines on B-Cell Lymphomas

06/15/2022

Robert Fee ;

Updated multiple times in 2022, the National Comprehensive Cancer Network (NCCN) Guidelines for B-Cell Lymphomas provide recommendations for the prevention, diagnosis, and management of malignancies.

Updated multiple times in 2022,...

06/15/2022

Journal of Clinical Pathways

Sponsored

Special Report

Expanded Indication for Zanubrutinib: Marginal Zone Lymphoma and Waldenström’s Macroglobulinemia

06/10/2022

In an interview with Journal of Clinical Pathways, Mitul Gandhi, MD, reviews the clinical impact and treatment approaches and challenges for patients with marginal zone lymphoma and Waldenström’s macroglobulinemia.

In an interview with Journal of...

06/10/2022

Journal of Clinical Pathways

JCP Special Report

Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group

05/20/2022

Robin T. Zon , MD, FACP, FASCO;

Gordon Kuntz ;

Winston Wong , PharmD;

The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...

The Journal of Clinical Pathways...

05/20/2022

Journal of Clinical Pathways

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

Sponsored

Special Report

Overview of the Updated NCCN Guidelines on Triple-Negative Breast Cancer

12/15/2021

Deborah Abrams Kaplan ;

NCCN released updates to its practice guidelines on treating triple-negative breast cancer, featuring updates on sacituzumab govitecan recommendations and more.

NCCN released updates to its...

12/15/2021

Journal of Clinical Pathways

Sponsored

Special Report

Navigating the Patient Journey for Unresectable Stage III Non-Small Cell Lung Cancer

09/16/2021

.ryan-test { display: none; } .body-content h3 { font-size: 18px; line-height: 18px; color: #000000; font-weight: 600px; } .related-content { display: none; } .body-content div > div:nth-of-type(3) .paragraph > h3 >...

.ryan-test { display:...

09/16/2021

Journal of Clinical Pathways

Journal of Clinical Pathways Newsletter

Column

Current Issue

Special Reports

Subscribe

Specialties

Events

Year Round Education

HMP Global Products